Trial | NCT01625871  Report issue

Title

Artemether/Lumefantrine and Vivax Malaria
Artemether/Lumefantrine in the Treatment of Plasmodium Vivax Malaria in Eastern Sudan

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    38
The cure rate of artemether/lumefantrine in the treatment of vivax malaria.
Study Started
Sep 30
2011
Primary Completion
Sep 30
2012
Study Completion
Sep 30
2012
Last Update
Jan 17
2013
Estimate

Drug tablets artemether/lumefantrine

six doses of oral tablets of artemether/lumefantrine

  • Other names: Quartem

artemether-lumefantrine Experimental

tablets (containing 20mg artemether and 120 mg lumefantrine) for three days

Criteria 

Inclusion Criteria:

Patients with vivax malaria

Exclusion Criteria:

severe malaria
pregnancy
No Results Posted